CTLT
Catalent, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -11.3% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2024 | 15 | 0 | 28.60M | $1.73B | +1 | −1 |
| Q2 2024 | 15 | — | 32.25M | $1.81B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 6.40M | +30.3% | $387.56M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Norges Bank ✦ (passief) | 4.79M | +4.3% | $289.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 4.52M | +10.7% | $273.65M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 4.27M | -1.0% | $257.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 4.27M | -1.0% | $257.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Elliott Investment Management ✦ | 4.00M | 0.0% | $242.28M | 2.3% | Held | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.16M | -41.0% | $70.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.16M | -41.0% | $70.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 1.05M | -22.1% | $63.51M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 364.54K | +39.7% | $22.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 285.30K | Nieuw | $17.28M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 285.16K | -94.2% | $17.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 285.16K | -94.2% | $17.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 60.38K | +1242.3% | $3.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 25.25K | -5.1% | $1.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 12.38K | +16.0% | $746,018 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 12.38K | +16.0% | $746,018 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 8.59K | -10.3% | $519,994 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Wellington Management ✦ | 8.59K | -10.3% | $519,994 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $17.28M | 0.0% |
Verlaten
| Bridgewater Associates | $1.92M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 1 aandelen, $63 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.